G017-1793 Screening compound: N-(2-{[2-(morpholin-4-yl)ethyl][(thiophen-2-yl)methyl]amino}ethyl)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine-7-sulfonamide

G017-1793 Screening compound: N-(2-{[2-(morpholin-4-yl)ethyl][(thiophen-2-yl)methyl]amino}ethyl)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine-7-sulfonamide
G017-1793 Screening compound: N-(2-{[2-(morpholin-4-yl)ethyl][(thiophen-2-yl)methyl]amino}ethyl)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine-7-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G017-1793
N-(2-{[2-(morpholin-4-yl)ethyl][(thiophen-2-yl)methyl]amino}ethyl)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine-7-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G017-1793

Molecular Formula

C23H32N4O4S2 (C23 H32 N4 O4 S2)

Compound Name

N-(2-{[2-(morpholin-4-yl)ethyl][(thiophen-2-yl)methyl]amino}ethyl)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine-7-sulfonamide

IUPAC name

N-(2-{[2-(morpholin-4-yl)ethyl][(thiophen-2-yl)methyl]amino}ethyl)-2-oxo-2345-tetrahydro-1H-1-benzazepine-7-sulfonamide

SMILES

O=C(CCC1)Nc(cc2)c1cc2S(NCCN(CCN1CCOCC1)Cc1cccs1)(=O)=O

InChI

InChI=1S/C23H32N4O4S2/c28-23-5-1-3-19-17-21(6-7-22(19)25-23)33(29,30)24-8-9-27(18-20-4-2-16-32-20)11-10-26-12-14-31-15-13-26/h2,4,6-7,16-17,24H,1,3,5,8-15,18H2,(H,25,28)

InChI Key

PBTNBYHSFIYCIT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14977382

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

492.66

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.632

Distribution Coefficient, logD

1.595

Water Solubility, LogSw

-2.63

Polar Surface Area

83.568

Acid Dissociation Constant (pKa)

11.28

Base Dissociation Constant (pKb)

6.36

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

52.20

G017-1793 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Allosteric Kinases Inhibitors Library (23117 compounds)

Antiviral Library (67538 compounds)

Protein-Protein Interaction Library (218420 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with G017-1793 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G017-1793?
Check Price and Availability of G017-1793, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G017-1793 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G017-1793
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G017-1793
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G017-1793 available by request